FDA Investigator Chase Bourke, PhD
Chase Bourke, PhD has inspections in 1 countries as of 30 Aug 2023. Chase Bourke, PhD has collaborated with a combined 535 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Charles R Bonapace, PhD,
Charles R Cote, RIC,
Corey K Reno,
Corey Reno,
Denise L Burosh,
Dina A Tallman,
Dr. Gopa Biswas, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Gajendiran Mahadevan, PhD,
Gopa Biswan,
Gregory W Smith,
Hyojong Kwon, PhD,
Jasjeet K Sekhon,
John A Kadavil, PhD,
Jyoti B Patel, PhD,
Kara A Scheibner, PhD,
Martin K Yau, PhD,
Michael F Skelly, PhD,
Mohsen Rajabi Abhari, FDA,
Ronald R Ruff,
Sandra A Hughes,
Scott B Laudenberg,
Scott B Laufenberg,
Scott B Lausanberg,
Scott B Loufoubery,
Xiaohan Cai, PhD
Chase Bourke, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2014 | EIR | Ppd Development, L.P. - EIR, 2014-02-13 |
February, 2014 | FDA 483 | Labcorp Early Development Laboratories, Inc. - Form 483, 2014-02-20 |
February, 2014 | EIR | Labcorp Early Development Laboratories, Inc. - EIR, 2014-02-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more